Drug Testing Market

Drug Testing Market by Component (Consumables, Instruments, Rapid Testing Devices, Services), Sample Type (Urine samples, Oral Fluid Samples, Hair Samples, Other Samples), by Drug Type (Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD, Other Drug Types), by End Use (Hospitals, Clinics, Other End-uses) and Region - 2023 to 2033

The global sales of the Drug Testing Market in 2022 were held at US$ 6.3 Bn. With a CAGR of 5.3% during 2023 - 2033, the market is projected to reach a valuation of US$ 15.7 Bn by 2033.

Consumables are expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 6.3% during 2023 – 2033.

Revenue of Drug Testing Market from 2018 to 2022 Compared to Demand Outlook for 2023 to 2033

As per the drug testing market research by Transparency Market Research - a market research and competitive intelligence provider, historically, from 2018 to 2022, the value of the market increased at around 4.6% CAGR.

To detect illicit and some prescription medications in biological samples drug testing is put to use. It is also used to screen blood and urine samples. Drug testing is also required for assessing the usage of drugs and is an essential component of therapy and evaluation. Drug testing is employed in hospitals and schools and in workplaces. It is also used for post-accident drug testing as well as for collegiate and professional athletes’ drug testing.

Furthermore, at the collegiate level and for professional athletes, sports drug testing is necessary to screen for illegal, recreational, or performance-enhancing medications. Heroin, cannabis, cocaine, ecstasy, and amphetamine are some of the most often used illegal narcotics.

Marijuana, Cocaine, oxycodone, ecstasy, opiates, methamphetamine, and other substances are detected by drug testing methods. Drug testing systems are utilized in treatment clinics, correctional facilities, and industrial settings. Substance testing is one of the fast-changing technologies used to detect the usage of a particular drug.

The progress of technology in devices, which increases sensitivity, reduces time, and detects newly invented designer drugs, is a major reason driving the expansion of drug testing systems.

Enhanced consumption of alcohol and opioids deteriorates health. Drug testing devices are in more demand because of the initiatives of the government to assist drug abusers. Because of more drug testing and its abuse, the market is likely to boost.

In recent times, advanced solutions for drug testing are likely to enter the market which is easy to use and precise. The use of illegal drugs is increasing rapidly in many developed and developing countries, which has a negative impact on individuals' physical and mental health. The market for drug testing systems is expected to be driven by rising drug and alcohol consumption during the forecast period.

What Factors are Propelling Drug Testing Demand?

Drug testing is in more demand because of Increasing drug and alcohol abuse, as well as the rising geriatric population which is putting a load on the drug testing market. Increasing government financial support and drug testing initiatives, and growing knowledge regarding drug testing in developed countries have created factors that would enhance the market growth. Additionally, as the consumption of drugs keeps on rising, it will continue to keep the market upside.

However, there are some restrictions in certain nations regarding drug testing since it is regarded as a breach of privacy rights. Also, accuracy concerns with breathalyzers and the ban on the consumption of substances are a few additional restrictions.

Region-wise Analysis

Which Region is Projected to Offer the Largest Opportunity for Drug Testing Market?

Due to an increase in the number of drug and alcohol addiction cases and the passage of rigorous legislation in the region, North America leads the global market for drug testing in the world owing to more cases of drug and alcohol addiction and the employment of stringent legislation region.

Other factors driving the region's enhanced performance include the existence of notable players executing substantial growth strategies and strict laws for workplace testing. Furthermore, attractive reimbursement conditions and the region's high adoption of technologically sophisticated solutions have fuelled drug testing market expansion.

During the projected period, the market in Asia Pacific is predicted to increase considerably. Countries such as China and India, which create a need for drug misuse testing, are important drivers of its expansion. These countries see the necessity for drug testing programs as a result of drug-related crime, road accidents, and substance addiction difficulties.

Country-wise Analysis

Which Country Lies at the Center Stage for Drug Testing Market Revenue?

The United States is expected to have the highest market share of US$ 5.5 Bn by the end of 2033. The United States experienced a harsher drug addiction epidemic during the COVID-19 pandemic. During the pandemic, more than one in every ten individuals began or increased their use of alcohol or drugs. As a result, the number of people dying as a result of a drug overdose has increased. This has significantly raised the demand for the drug testing business in the United States.

Category-wise Insights

Which Product Type is expected to see the highest growth in the forecasted period?

Consumables commanded the largest revenue in this regard and grew at a CAGR of nearly 5% during 2015-21 and are now forecasted to grow at a CAGR of 6.3% throughout the forecasted period.

The increased availability of modern consumables that give enhanced solutions for making testing simple, precise, and quick has propelled drug screening market expansion.

The service category had the second-largest share in revenue in 2020. The segment has expanded through a number of strategic activities such as acquisitions by numerous organizations along with association and alliance formation to serve public safety and government agencies.

Which is the largest end-user for Drug Testing Providers?

Drug Testing Laboratories commanded the largest revenue in this regard and grew at a CAGR of nearly 6% during 2018-22 and are forecasted to grow at a CAGR of 5.8% throughout the forecasted period.

This large proportion can be attributable to their widespread acceptance as a consequence of their precise outcomes. Rapid tests cannot detect the presence of any illicit substance, whereas drug testing facilities can. As a result, laboratories produce more sensitive and specific testing findings than fast tests.

What is the impact of Covid-19 on the Drug Testing Market?

Drug traffickers have swiftly rebounded from early setbacks caused by lockdown limitations, owing to an increase in the use of technology. These reasons have been raising the demand for drug testing products.

Travel restrictions and lockdowns, as well as restrictions on corporate operations, public gatherings, and shelter-in-place orders, have hampered the market expansion. Several governments throughout the world have announced countrywide lockdowns and temporary closures of industries, manufacturing, production, and commercial development. Trade obstacles have exacerbated the demand-supply imbalance. Customers in the drug testing business have seen interruptions in the global supply chain, diminished demand, or the cessation of operations.

Competitive Analysis

To grab higher market shares, key corporations are pursuing various growth methods such as new product development, mergers and acquisitions, and regional expansion.

Some of the key players operating in the drug testing industry include Quest Diagnostics Incorporated, Abbott Laboratories, Quidel Corporation, F. Hoffmann-La Roche, Thermo Fisher Scientific, Inc., Gene By Gene, Ltd., 23andMe, Inc., Color Genomics, Inc., Myriad Genetics, Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., bioMerieux SA, Quest Diagnostics, Aeromedevac, Air Methods, ALPHASTAR, and Babcock Scandinavian AirAmbulance.

Some of the recent developments in key drug testing companies are as follows:

  • In December 2020, Clinical Reference Laboratory acquired Confirm BioSciences, which is one of the leading providers of comprehensive testing tools and solutions, aiding in the expansion of Confirm's access to lab testing services and research and development capabilities, which may help CRL due to Confirm's huge customer base in drug abuse testing.
  • In April 2020, Cordant Health Solutions started an oral fluid drug testing solution based on telemedicine to assist in offering critical care to individuals recovering from substance use disorder.
  • In April 2019, Thermo Fisher Scientific launched CEDIA Mitragynine Assay for criminal justice and forensic use.

Similarly, recent developments related to the companies in the Drug Testing business have been tracked by the team at Transparency Market Research, which is available in the full report.

Market Segments Covered in Drug Testing Market Analysis

By Component

  • Consumables
  • Instruments
  • Rapid Testing Devices
  • Services

By Sample Type

  • Urine samples
  • Oral Fluid Samples
  • Hair Sample
  • Other Samples

By Drug Type

  • Alcohol
  • Cannabis/Marijuana
  • Cocaine
  • Opioids
  • Amphetamine & Methamphetamine
  • LSD
  • Other Drug Types

By End Use

  • Hospitals
  • Clinics
  • Other End Uses

By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Drug Screening Market Snapshot

Attribute

Details

Global Drug Testing Market (2023)

US$ 9.4 Bn

Global Drug Testing Industry (2033)

US$ 15.7 Bn

Global Drug Screening Market CAGR (2023 – 2033)

5.3%

U.S. Drug Testing Market CAGR (2023 – 2033)

6%

Key Companies Profiled

  • Quest Diagnostics Incorporated
  • Abbott Laboratories
  • Quidel Corporation
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific, Inc.
  • Gene By Gene, Ltd.
  • 23andMe, Inc.
  • Color Genomics, Inc.
  • Myriad Genetics, Inc.
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Quest Diagnostics
  • Aeromedevac
  • Air Methods
  • ALPHASTAR
  • Babcock Scandinavian AirAmbulance

 

Frequently Asked Questions

How much is the current worth of the drug testing market?

The market is worth more than US$ 6.3 Bn at present.

What is the sales forecast for drug testing industry?

The market value is projected to increase at a CAGR of around 5.3% during 2023 – 2033.

What was the last 5 year’s market CAGR?

The market value increased at a CAGR of around 4.6% during 2018 – 2022.

What is a key trend shaping the growth of the market?

Growing drug and alcohol addiction, a growing elderly population, high use of alcohol and prescription and illegal drugs, and a growing worldwide population are some of the primary reasons driving the global drug testing market's rise.

At what percentage is sales of Drug Testing Market going to register growth in China?

The market of drug testing in China is projected to expand at a CAGR of around 6.3% during 2023 – 2033.

What do statistics for South Korea and Japan reveal?

While the market in South Korea is expected to grow at nearly 4.9%, the market in Japan is projected to register a CAGR of nearly 4.6% during 2023 - 2033.

    1. Executive Summary

        1.1. Global Market Outlook

        1.2. Demand-side Trends

        1.3. Supply-side Trends

        1.4. Technology Roadmap Analysis

        1.5. Analysis and Recommendations

    2. Market Overview

        2.1. Market Coverage / Taxonomy

        2.2. Market Definition / Scope / Limitations

    3. Market Background

        3.1. Market Dynamics

            3.1.1. Drivers

            3.1.2. Restraints

            3.1.3. Opportunity

            3.1.4. Trends

        3.2. Scenario Forecast

            3.2.1. Demand in Optimistic Scenario

            3.2.2. Demand in Likely Scenario

            3.2.3. Demand in Conservative Scenario

        3.3. Opportunity Map Analysis

        3.4. Investment Feasibility Matrix

        3.5. PESTLE and Porter’s Analysis

        3.6. Regulatory Landscape

            3.6.1. By Key Regions

            3.6.2. By Key Countries

        3.7. Regional Parent Market Outlook

    4. Global Drug Testing Market Analysis 2018-2022 and Forecast, 2023-2033

        4.1. Historical Market Size Value (US$ Mn) Analysis, 2018-2022

        4.2. Current and Future Market Size Value (US$ Mn) Projections, 2023-2033

            4.2.1. Y-o-Y Growth Trend Analysis

            4.2.2. Absolute $ Opportunity Analysis

    5. Global Drug Testing Market Analysis 2018-2022 and Forecast 2023-2033, By Component

        5.1. Introduction / Key Findings

        5.2. Historical Market Size Value (US$ Mn) Analysis By Component , 2018-2022

        5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Component , 2023-2033

            5.3.1. Consumables

            5.3.2. Instruments

            5.3.3. Rapid Testing Devices

            5.3.4. Services

        5.4. Y-o-Y Growth Trend Analysis By Component , 2018-2022

        5.5. Absolute $ Opportunity Analysis By Component , 2023-2033

    6. Global Drug Testing Market Analysis 2018-2022 and Forecast 2023-2033, By Sample Type

        6.1. Introduction / Key Findings

        6.2. Historical Market Size Value (US$ Mn) Analysis By Sample Type, 2018-2022

        6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Sample Type, 2023-2033

            6.3.1. Urine Samples

            6.3.2. Oral Fluid Samples

            6.3.3. Hair Samples

            6.3.4. Other Samples

        6.4. Y-o-Y Growth Trend Analysis By Sample Type, 2018-2022

        6.5. Absolute $ Opportunity Analysis By Sample Type, 2023-2033

    7. Global Drug Testing Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Type

        7.1. Introduction / Key Findings

        7.2. Historical Market Size Value (US$ Mn) Analysis By Drug Type , 2018-2022

        7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Drug Type , 2023-2033

            7.3.1. Alcohol

            7.3.2. Cannabis/Marijuana

            7.3.3. Cocaine

            7.3.4. Opioids

            7.3.5. Amphetamine & Methamphetamine

            7.3.6. LSD

            7.3.7. Other Drug Types

        7.4. Y-o-Y Growth Trend Analysis By Drug Type , 2018-2022

        7.5. Absolute $ Opportunity Analysis By Drug Type , 2023-2033

    8. Global Drug Testing Market Analysis 2018-2022 and Forecast 2023-2033, By End-use

        8.1. Introduction / Key Findings

        8.2. Historical Market Size Value (US$ Mn) Analysis By End-use, 2018-2022

        8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-use, 2023-2033

            8.3.1. Hospitals

            8.3.2. Clinics

            8.3.3. Other End-uses

        8.4. Y-o-Y Growth Trend Analysis By End-use, 2018-2022

        8.5. Absolute $ Opportunity Analysis By End-use, 2023-2033

    9. Global Drug Testing Market Analysis 2018-2022 and Forecast 2023-2033, By Region

        9.1. Introduction

        9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2018-2022

        9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2023-2033

            9.3.1. North America

            9.3.2. Latin America

            9.3.3. Europe

            9.3.4. Asia Pacific

            9.3.5. Middle East and Africa

        9.4. Market Attractiveness Analysis By Region

    10. North America Drug Testing Market Analysis 2018-2022 and Forecast 2023-2033, By Country

        10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

        10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

            10.2.1. By Country

                10.2.1.1. U.S.

                10.2.1.2. Canada

            10.2.2. By Component

            10.2.3. By Sample Type

            10.2.4. By Drug Type

            10.2.5. By End-use

        10.3. Market Attractiveness Analysis

            10.3.1. By Country

            10.3.2. By Component

            10.3.3. By Sample Type

            10.3.4. By Drug Type

            10.3.5. By End-use

        10.4. Key Takeaways

    11. Latin America Drug Testing Market Analysis 2018-2022 and Forecast 2023-2033, By Country

        11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

        11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

            11.2.1. By Country

                11.2.1.1. Brazil

                11.2.1.2. Mexico

                11.2.1.3. Rest of Latin America

            11.2.2. By Component

            11.2.3. By Sample Type

            11.2.4. By Drug Type

            11.2.5. By End-use

        11.3. Market Attractiveness Analysis

            11.3.1. By Country

            11.3.2. By Component

            11.3.3. By Sample Type

            11.3.4. By Drug Type

            11.3.5. By End-use

        11.4. Key Takeaways

    12. Europe Drug Testing Market Analysis 2018-2022 and Forecast 2023-2033, By Country

        12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

        12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

            12.2.1. By Country

                12.2.1.1. Germany

                12.2.1.2. Italy

                12.2.1.3. France

                12.2.1.4. U.K.

                12.2.1.5. Russia

                12.2.1.6. BENELUX

                12.2.1.7. Rest of Europe

            12.2.2. By Component

            12.2.3. By Sample Type

            12.2.4. By Drug Type

            12.2.5. By End-use

        12.3. Market Attractiveness Analysis

            12.3.1. By Country

            12.3.2. By Component

            12.3.3. By Sample Type

            12.3.4. By Drug Type

            12.3.5. By End-use

        12.4. Key Takeaways

    13. Asia Pacific Drug Testing Market Analysis 2018-2022 and Forecast 2023-2033, By Country

        13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

        13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

            13.2.1. By Country

                13.2.1.1. China

                13.2.1.2. Japan

                13.2.1.3. South Korea

                13.2.1.4. Rest of Asia Pacific

            13.2.2. By Component

            13.2.3. By Sample Type

            13.2.4. By Drug Type

            13.2.5. By End-use

        13.3. Market Attractiveness Analysis

            13.3.1. By Country

            13.3.2. By Component

            13.3.3. By Sample Type

            13.3.4. By Drug Type

            13.3.5. By End-use

        13.4. Key Takeaways

    14. Middle East and Africa Drug Testing Market Analysis 2018-2022 and Forecast 2023-2033, By Country

        14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

        14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

            14.2.1. By Country

                14.2.1.1. GCC Countries

                14.2.1.2. South Africa

                14.2.1.3. Turkey

                14.2.1.4. Rest of Middle East and Africa

            14.2.2. By Component

            14.2.3. By Sample Type

            14.2.4. By Drug Type

            14.2.5. By End-use

        14.3. Market Attractiveness Analysis

            14.3.1. By Country

            14.3.2. By Component

            14.3.3. By Sample Type

            14.3.4. By Drug Type

            14.3.5. By End-use

        14.4. Key Takeaways

    15. Key Countries Drug Testing Market Analysis

        15.1. U.S.

            15.1.1. Pricing Analysis

            15.1.2. Market Share Analysis, 2022

                15.1.2.1. By Component

                15.1.2.2. By Sample Type

                15.1.2.3. By Drug Type

                15.1.2.4. By End-use

        15.2. Canada

            15.2.1. Pricing Analysis

            15.2.2. Market Share Analysis, 2022

                15.2.2.1. By Component

                15.2.2.2. By Sample Type

                15.2.2.3. By Drug Type

                15.2.2.4. By End-use

        15.3. Brazil

            15.3.1. Pricing Analysis

            15.3.2. Market Share Analysis, 2022

                15.3.2.1. By Component

                15.3.2.2. By Sample Type

                15.3.2.3. By Drug Type

                15.3.2.4. By End-use

        15.4. Mexico

            15.4.1. Pricing Analysis

            15.4.2. Market Share Analysis, 2022

                15.4.2.1. By Component

                15.4.2.2. By Sample Type

                15.4.2.3. By Drug Type

                15.4.2.4. By End-use

        15.5. Germany

            15.5.1. Pricing Analysis

            15.5.2. Market Share Analysis, 2022

                15.5.2.1. By Component

                15.5.2.2. By Sample Type

                15.5.2.3. By Drug Type

                15.5.2.4. By End-use

        15.6. Italy

            15.6.1. Pricing Analysis

            15.6.2. Market Share Analysis, 2022

                15.6.2.1. By Component

                15.6.2.2. By Sample Type

                15.6.2.3. By Drug Type

                15.6.2.4. By End-use

        15.7. France

            15.7.1. Pricing Analysis

            15.7.2. Market Share Analysis, 2022

                15.7.2.1. By Component

                15.7.2.2. By Sample Type

                15.7.2.3. By Drug Type

                15.7.2.4. By End-use

        15.8. U.K.

            15.8.1. Pricing Analysis

            15.8.2. Market Share Analysis, 2022

                15.8.2.1. By Component

                15.8.2.2. By Sample Type

                15.8.2.3. By Drug Type

                15.8.2.4. By End-use

        15.9. Russia

            15.9.1. Pricing Analysis

            15.9.2. Market Share Analysis, 2022

                15.9.2.1. By Component

                15.9.2.2. By Sample Type

                15.9.2.3. By Drug Type

                15.9.2.4. By End-use

        15.10. BENELUX

            15.10.1. Pricing Analysis

            15.10.2. Market Share Analysis, 2022

                15.10.2.1. By Component

                15.10.2.2. By Sample Type

                15.10.2.3. By Drug Type

                15.10.2.4. By End-use

        15.11. China

            15.11.1. Pricing Analysis

            15.11.2. Market Share Analysis, 2022

                15.11.2.1. By Component

                15.11.2.2. By Sample Type

                15.11.2.3. By Drug Type

                15.11.2.4. By End-use

        15.12. Japan

            15.12.1. Pricing Analysis

            15.12.2. Market Share Analysis, 2022

                15.12.2.1. By Component

                15.12.2.2. By Sample Type

                15.12.2.3. By Drug Type

                15.12.2.4. By End-use

        15.13. South Korea

            15.13.1. Pricing Analysis

            15.13.2. Market Share Analysis, 2022

                15.13.2.1. By Component

                15.13.2.2. By Sample Type

                15.13.2.3. By Drug Type

                15.13.2.4. By End-use

        15.14. GCC Countries

            15.14.1. Pricing Analysis

            15.14.2. Market Share Analysis, 2022

                15.14.2.1. By Component

                15.14.2.2. By Sample Type

                15.14.2.3. By Drug Type

                15.14.2.4. By End-use

        15.15. South Africa

            15.15.1. Pricing Analysis

            15.15.2. Market Share Analysis, 2022

                15.15.2.1. By Component

                15.15.2.2. By Sample Type

                15.15.2.3. By Drug Type

                15.15.2.4. By End-use

        15.16. Turkey

            15.16.1. Pricing Analysis

            15.16.2. Market Share Analysis, 2022

                15.16.2.1. By Component

                15.16.2.2. By Sample Type

                15.16.2.3. By Drug Type

                15.16.2.4. By End-use

    16. Market Structure Analysis

        16.1. Competition Dashboard

        16.2. Competition Benchmarking

        16.3. Market Share Analysis of Top Players

            16.3.1. By Regional

            16.3.2. By Component

            16.3.3. By Sample Type

            16.3.4. By Drug Type

            16.3.5. By End-use

    17. Competition Analysis

        17.1. Competition Deep Dive

            17.1.1. Quest Diagnostics Incorporated

                17.1.1.1. Overview

                17.1.1.2. Product Portfolio

                17.1.1.3. Profitability by Market Segments

                17.1.1.4. Sales Footprint

                17.1.1.5. Strategy Overview

                    17.1.1.5.1. Marketing Strategy

            17.1.2. Abbott Laboratories

                17.1.2.1. Overview

                17.1.2.2. Product Portfolio

                17.1.2.3. Profitability by Market Segments

                17.1.2.4. Sales Footprint

                17.1.2.5. Strategy Overview

                    17.1.2.5.1. Marketing Strategy

            17.1.3. Quidel Corporation

                17.1.3.1. Overview

                17.1.3.2. Product Portfolio

                17.1.3.3. Profitability by Market Segments

                17.1.3.4. Sales Footprint

                17.1.3.5. Strategy Overview

                    17.1.3.5.1. Marketing Strategy

            17.1.4. F. Hoffmann-La Roche

                17.1.4.1. Overview

                17.1.4.2. Product Portfolio

                17.1.4.3. Profitability by Market Segments

                17.1.4.4. Sales Footprint

                17.1.4.5. Strategy Overview

                    17.1.4.5.1. Marketing Strategy

            17.1.5. Thermo Fisher Scientific, Inc.

                17.1.5.1. Overview

                17.1.5.2. Product Portfolio

                17.1.5.3. Profitability by Market Segments

                17.1.5.4. Sales Footprint

                17.1.5.5. Strategy Overview

                    17.1.5.5.1. Marketing Strategy

            17.1.6. Siemens Healthineers

                17.1.6.1. Overview

                17.1.6.2. Product Portfolio

                17.1.6.3. Profitability by Market Segments

                17.1.6.4. Sales Footprint

                17.1.6.5. Strategy Overview

                    17.1.6.5.1. Marketing Strategy

            17.1.7. Bio-Rad Laboratories, Inc.

                17.1.7.1. Overview

                17.1.7.2. Product Portfolio

                17.1.7.3. Profitability by Market Segments

                17.1.7.4. Sales Footprint

                17.1.7.5. Strategy Overview

                    17.1.7.5.1. Marketing Strategy

            17.1.8. Agilent Technologies, Inc.

                17.1.8.1. Overview

                17.1.8.2. Product Portfolio

                17.1.8.3. Profitability by Market Segments

                17.1.8.4. Sales Footprint

                17.1.8.5. Strategy Overview

                    17.1.8.5.1. Marketing Strategy

            17.1.9. LabCorp

                17.1.9.1. Overview

                17.1.9.2. Product Portfolio

                17.1.9.3. Profitability by Market Segments

                17.1.9.4. Sales Footprint

                17.1.9.5. Strategy Overview

                    17.1.9.5.1. Marketing Strategy

            17.1.10. Drägerwerk AG & CO. KGaA

                17.1.10.1. Overview

                17.1.10.2. Product Portfolio

                17.1.10.3. Profitability by Market Segments

                17.1.10.4. Sales Footprint

                17.1.10.5. Strategy Overview

                    17.1.10.5.1. Marketing Strategy

            17.1.11. Clinical Reference Laboratory (CRL), Inc.

                17.1.11.1. Overview

                17.1.11.2. Product Portfolio

                17.1.11.3. Profitability by Market Segments

                17.1.11.4. Sales Footprint

                17.1.11.5. Strategy Overview

                    17.1.11.5.1. Marketing Strategy

            17.1.12. Cordant Health Solutions

                17.1.12.1. Overview

                17.1.12.2. Product Portfolio

                17.1.12.3. Profitability by Market Segments

                17.1.12.4. Sales Footprint

                17.1.12.5. Strategy Overview

                    17.1.12.5.1. Marketing Strategy

            17.1.13. Legacy Medical Services, LLC

                17.1.13.1. Overview

                17.1.13.2. Product Portfolio

                17.1.13.3. Profitability by Market Segments

                17.1.13.4. Sales Footprint

                17.1.13.5. Strategy Overview

                    17.1.13.5.1. Marketing Strategy

            17.1.14. Omega Laboratories, Inc.

                17.1.14.1. Overview

                17.1.14.2. Product Portfolio

                17.1.14.3. Profitability by Market Segments

                17.1.14.4. Sales Footprint

                17.1.14.5. Strategy Overview

                    17.1.14.5.1. Marketing Strategy

    18. Assumptions & Acronyms Used

    19. Research Methodology

    List of Tables

    Table 1: Global Drug Testing Market Value (US$ Mn) Forecast by Region, 2018-2033

    Table 2: Global Drug Testing Market Value (US$ Mn) Forecast by Component , 2018-2033

    Table 3: Global Drug Testing Market Value (US$ Mn) Forecast by Sample Type, 2018-2033

    Table 4: Global Drug Testing Market Value (US$ Mn) Forecast by Drug Type , 2018-2033

    Table 5: Global Drug Testing Market Value (US$ Mn) Forecast by End-use, 2018-2033

    Table 6: North America Drug Testing Market Value (US$ Mn) Forecast by Country, 2018-2033

    Table 7: North America Drug Testing Market Value (US$ Mn) Forecast by Component , 2018-2033

    Table 8: North America Drug Testing Market Value (US$ Mn) Forecast by Sample Type, 2018-2033

    Table 9: North America Drug Testing Market Value (US$ Mn) Forecast by Drug Type , 2018-2033

    Table 10: North America Drug Testing Market Value (US$ Mn) Forecast by End-use, 2018-2033

    Table 11: Latin America Drug Testing Market Value (US$ Mn) Forecast by Country, 2018-2033

    Table 12: Latin America Drug Testing Market Value (US$ Mn) Forecast by Component , 2018-2033

    Table 13: Latin America Drug Testing Market Value (US$ Mn) Forecast by Sample Type, 2018-2033

    Table 14: Latin America Drug Testing Market Value (US$ Mn) Forecast by Drug Type , 2018-2033

    Table 15: Latin America Drug Testing Market Value (US$ Mn) Forecast by End-use, 2018-2033

    Table 16: Europe Drug Testing Market Value (US$ Mn) Forecast by Country, 2018-2033

    Table 17: Europe Drug Testing Market Value (US$ Mn) Forecast by Component , 2018-2033

    Table 18: Europe Drug Testing Market Value (US$ Mn) Forecast by Sample Type, 2018-2033

    Table 19: Europe Drug Testing Market Value (US$ Mn) Forecast by Drug Type , 2018-2033

    Table 20: Europe Drug Testing Market Value (US$ Mn) Forecast by End-use, 2018-2033

    Table 21: Asia Pacific Drug Testing Market Value (US$ Mn) Forecast by Country, 2018-2033

    Table 22: Asia Pacific Drug Testing Market Value (US$ Mn) Forecast by Component , 2018-2033

    Table 23: Asia Pacific Drug Testing Market Value (US$ Mn) Forecast by Sample Type, 2018-2033

    Table 24: Asia Pacific Drug Testing Market Value (US$ Mn) Forecast by Drug Type , 2018-2033

    Table 25: Asia Pacific Drug Testing Market Value (US$ Mn) Forecast by End-use, 2018-2033

    Table 26: Middle East and Africa Drug Testing Market Value (US$ Mn) Forecast by Country, 2018-2033

    Table 27: Middle East and Africa Drug Testing Market Value (US$ Mn) Forecast by Component , 2018-2033

    Table 28: Middle East and Africa Drug Testing Market Value (US$ Mn) Forecast by Sample Type, 2018-2033

    Table 29: Middle East and Africa Drug Testing Market Value (US$ Mn) Forecast by Drug Type , 2018-2033

    Table 30: Middle East and Africa Drug Testing Market Value (US$ Mn) Forecast by End-use, 2018-2033

    List of Figures

    Figure 1: Global Drug Testing Market Value (US$ Mn) by Component , 2023-2033

    Figure 2: Global Drug Testing Market Value (US$ Mn) by Sample Type, 2023-2033

    Figure 3: Global Drug Testing Market Value (US$ Mn) by Drug Type , 2023-2033

    Figure 4: Global Drug Testing Market Value (US$ Mn) by End-use, 2023-2033

    Figure 5: Global Drug Testing Market Value (US$ Mn) by Region, 2023-2033

    Figure 6: Global Drug Testing Market Value (US$ Mn) Analysis by Region, 2018-2033

    Figure 7: Global Drug Testing Market Value Share (%) and BPS Analysis by Region, 2023-2033

    Figure 8: Global Drug Testing Market Y-o-Y Growth (%) Projections by Region, 2023-2033

    Figure 9: Global Drug Testing Market Value (US$ Mn) Analysis by Component , 2018-2033

    Figure 10: Global Drug Testing Market Value Share (%) and BPS Analysis by Component , 2023-2033

    Figure 11: Global Drug Testing Market Y-o-Y Growth (%) Projections by Component , 2023-2033

    Figure 12: Global Drug Testing Market Value (US$ Mn) Analysis by Sample Type, 2018-2033

    Figure 13: Global Drug Testing Market Value Share (%) and BPS Analysis by Sample Type, 2023-2033

    Figure 14: Global Drug Testing Market Y-o-Y Growth (%) Projections by Sample Type, 2023-2033

    Figure 15: Global Drug Testing Market Value (US$ Mn) Analysis by Drug Type , 2018-2033

    Figure 16: Global Drug Testing Market Value Share (%) and BPS Analysis by Drug Type , 2023-2033

    Figure 17: Global Drug Testing Market Y-o-Y Growth (%) Projections by Drug Type , 2023-2033

    Figure 18: Global Drug Testing Market Value (US$ Mn) Analysis by End-use, 2018-2033

    Figure 19: Global Drug Testing Market Value Share (%) and BPS Analysis by End-use, 2023-2033

    Figure 20: Global Drug Testing Market Y-o-Y Growth (%) Projections by End-use, 2023-2033

    Figure 21: Global Drug Testing Market Attractiveness by Component , 2023-2033

    Figure 22: Global Drug Testing Market Attractiveness by Sample Type, 2023-2033

    Figure 23: Global Drug Testing Market Attractiveness by Drug Type , 2023-2033

    Figure 24: Global Drug Testing Market Attractiveness by End-use, 2023-2033

    Figure 25: Global Drug Testing Market Attractiveness by Region, 2023-2033

    Figure 26: North America Drug Testing Market Value (US$ Mn) by Component , 2023-2033

    Figure 27: North America Drug Testing Market Value (US$ Mn) by Sample Type, 2023-2033

    Figure 28: North America Drug Testing Market Value (US$ Mn) by Drug Type , 2023-2033

    Figure 29: North America Drug Testing Market Value (US$ Mn) by End-use, 2023-2033

    Figure 30: North America Drug Testing Market Value (US$ Mn) by Country, 2023-2033

    Figure 31: North America Drug Testing Market Value (US$ Mn) Analysis by Country, 2018-2033

    Figure 32: North America Drug Testing Market Value Share (%) and BPS Analysis by Country, 2023-2033

    Figure 33: North America Drug Testing Market Y-o-Y Growth (%) Projections by Country, 2023-2033

    Figure 34: North America Drug Testing Market Value (US$ Mn) Analysis by Component , 2018-2033

    Figure 35: North America Drug Testing Market Value Share (%) and BPS Analysis by Component , 2023-2033

    Figure 36: North America Drug Testing Market Y-o-Y Growth (%) Projections by Component , 2023-2033

    Figure 37: North America Drug Testing Market Value (US$ Mn) Analysis by Sample Type, 2018-2033

    Figure 38: North America Drug Testing Market Value Share (%) and BPS Analysis by Sample Type, 2023-2033

    Figure 39: North America Drug Testing Market Y-o-Y Growth (%) Projections by Sample Type, 2023-2033

    Figure 40: North America Drug Testing Market Value (US$ Mn) Analysis by Drug Type , 2018-2033

    Figure 41: North America Drug Testing Market Value Share (%) and BPS Analysis by Drug Type , 2023-2033

    Figure 42: North America Drug Testing Market Y-o-Y Growth (%) Projections by Drug Type , 2023-2033

    Figure 43: North America Drug Testing Market Value (US$ Mn) Analysis by End-use, 2018-2033

    Figure 44: North America Drug Testing Market Value Share (%) and BPS Analysis by End-use, 2023-2033

    Figure 45: North America Drug Testing Market Y-o-Y Growth (%) Projections by End-use, 2023-2033

    Figure 46: North America Drug Testing Market Attractiveness by Component , 2023-2033

    Figure 47: North America Drug Testing Market Attractiveness by Sample Type, 2023-2033

    Figure 48: North America Drug Testing Market Attractiveness by Drug Type , 2023-2033

    Figure 49: North America Drug Testing Market Attractiveness by End-use, 2023-2033

    Figure 50: North America Drug Testing Market Attractiveness by Country, 2023-2033

    Figure 51: Latin America Drug Testing Market Value (US$ Mn) by Component , 2023-2033

    Figure 52: Latin America Drug Testing Market Value (US$ Mn) by Sample Type, 2023-2033

    Figure 53: Latin America Drug Testing Market Value (US$ Mn) by Drug Type , 2023-2033

    Figure 54: Latin America Drug Testing Market Value (US$ Mn) by End-use, 2023-2033

    Figure 55: Latin America Drug Testing Market Value (US$ Mn) by Country, 2023-2033

    Figure 56: Latin America Drug Testing Market Value (US$ Mn) Analysis by Country, 2018-2033

    Figure 57: Latin America Drug Testing Market Value Share (%) and BPS Analysis by Country, 2023-2033

    Figure 58: Latin America Drug Testing Market Y-o-Y Growth (%) Projections by Country, 2023-2033

    Figure 59: Latin America Drug Testing Market Value (US$ Mn) Analysis by Component , 2018-2033

    Figure 60: Latin America Drug Testing Market Value Share (%) and BPS Analysis by Component , 2023-2033

    Figure 61: Latin America Drug Testing Market Y-o-Y Growth (%) Projections by Component , 2023-2033

    Figure 62: Latin America Drug Testing Market Value (US$ Mn) Analysis by Sample Type, 2018-2033

    Figure 63: Latin America Drug Testing Market Value Share (%) and BPS Analysis by Sample Type, 2023-2033

    Figure 64: Latin America Drug Testing Market Y-o-Y Growth (%) Projections by Sample Type, 2023-2033

    Figure 65: Latin America Drug Testing Market Value (US$ Mn) Analysis by Drug Type , 2018-2033

    Figure 66: Latin America Drug Testing Market Value Share (%) and BPS Analysis by Drug Type , 2023-2033

    Figure 67: Latin America Drug Testing Market Y-o-Y Growth (%) Projections by Drug Type , 2023-2033

    Figure 68: Latin America Drug Testing Market Value (US$ Mn) Analysis by End-use, 2018-2033

    Figure 69: Latin America Drug Testing Market Value Share (%) and BPS Analysis by End-use, 2023-2033

    Figure 70: Latin America Drug Testing Market Y-o-Y Growth (%) Projections by End-use, 2023-2033

    Figure 71: Latin America Drug Testing Market Attractiveness by Component , 2023-2033

    Figure 72: Latin America Drug Testing Market Attractiveness by Sample Type, 2023-2033

    Figure 73: Latin America Drug Testing Market Attractiveness by Drug Type , 2023-2033

    Figure 74: Latin America Drug Testing Market Attractiveness by End-use, 2023-2033

    Figure 75: Latin America Drug Testing Market Attractiveness by Country, 2023-2033

    Figure 76: Europe Drug Testing Market Value (US$ Mn) by Component , 2023-2033

    Figure 77: Europe Drug Testing Market Value (US$ Mn) by Sample Type, 2023-2033

    Figure 78: Europe Drug Testing Market Value (US$ Mn) by Drug Type , 2023-2033

    Figure 79: Europe Drug Testing Market Value (US$ Mn) by End-use, 2023-2033

    Figure 80: Europe Drug Testing Market Value (US$ Mn) by Country, 2023-2033

    Figure 81: Europe Drug Testing Market Value (US$ Mn) Analysis by Country, 2018-2033

    Figure 82: Europe Drug Testing Market Value Share (%) and BPS Analysis by Country, 2023-2033

    Figure 83: Europe Drug Testing Market Y-o-Y Growth (%) Projections by Country, 2023-2033

    Figure 84: Europe Drug Testing Market Value (US$ Mn) Analysis by Component , 2018-2033

    Figure 85: Europe Drug Testing Market Value Share (%) and BPS Analysis by Component , 2023-2033

    Figure 86: Europe Drug Testing Market Y-o-Y Growth (%) Projections by Component , 2023-2033

    Figure 87: Europe Drug Testing Market Value (US$ Mn) Analysis by Sample Type, 2018-2033

    Figure 88: Europe Drug Testing Market Value Share (%) and BPS Analysis by Sample Type, 2023-2033

    Figure 89: Europe Drug Testing Market Y-o-Y Growth (%) Projections by Sample Type, 2023-2033

    Figure 90: Europe Drug Testing Market Value (US$ Mn) Analysis by Drug Type , 2018-2033

    Figure 91: Europe Drug Testing Market Value Share (%) and BPS Analysis by Drug Type , 2023-2033

    Figure 92: Europe Drug Testing Market Y-o-Y Growth (%) Projections by Drug Type , 2023-2033

    Figure 93: Europe Drug Testing Market Value (US$ Mn) Analysis by End-use, 2018-2033

    Figure 94: Europe Drug Testing Market Value Share (%) and BPS Analysis by End-use, 2023-2033

    Figure 95: Europe Drug Testing Market Y-o-Y Growth (%) Projections by End-use, 2023-2033

    Figure 96: Europe Drug Testing Market Attractiveness by Component , 2023-2033

    Figure 97: Europe Drug Testing Market Attractiveness by Sample Type, 2023-2033

    Figure 98: Europe Drug Testing Market Attractiveness by Drug Type , 2023-2033

    Figure 99: Europe Drug Testing Market Attractiveness by End-use, 2023-2033

    Figure 100: Europe Drug Testing Market Attractiveness by Country, 2023-2033

    Figure 101: Asia Pacific Drug Testing Market Value (US$ Mn) by Component , 2023-2033

    Figure 102: Asia Pacific Drug Testing Market Value (US$ Mn) by Sample Type, 2023-2033

    Figure 103: Asia Pacific Drug Testing Market Value (US$ Mn) by Drug Type , 2023-2033

    Figure 104: Asia Pacific Drug Testing Market Value (US$ Mn) by End-use, 2023-2033

    Figure 105: Asia Pacific Drug Testing Market Value (US$ Mn) by Country, 2023-2033

    Figure 106: Asia Pacific Drug Testing Market Value (US$ Mn) Analysis by Country, 2018-2033

    Figure 107: Asia Pacific Drug Testing Market Value Share (%) and BPS Analysis by Country, 2023-2033

    Figure 108: Asia Pacific Drug Testing Market Y-o-Y Growth (%) Projections by Country, 2023-2033

    Figure 109: Asia Pacific Drug Testing Market Value (US$ Mn) Analysis by Component , 2018-2033

    Figure 110: Asia Pacific Drug Testing Market Value Share (%) and BPS Analysis by Component , 2023-2033

    Figure 111: Asia Pacific Drug Testing Market Y-o-Y Growth (%) Projections by Component , 2023-2033

    Figure 112: Asia Pacific Drug Testing Market Value (US$ Mn) Analysis by Sample Type, 2018-2033

    Figure 113: Asia Pacific Drug Testing Market Value Share (%) and BPS Analysis by Sample Type, 2023-2033

    Figure 114: Asia Pacific Drug Testing Market Y-o-Y Growth (%) Projections by Sample Type, 2023-2033

    Figure 115: Asia Pacific Drug Testing Market Value (US$ Mn) Analysis by Drug Type , 2018-2033

    Figure 116: Asia Pacific Drug Testing Market Value Share (%) and BPS Analysis by Drug Type , 2023-2033

    Figure 117: Asia Pacific Drug Testing Market Y-o-Y Growth (%) Projections by Drug Type , 2023-2033

    Figure 118: Asia Pacific Drug Testing Market Value (US$ Mn) Analysis by End-use, 2018-2033

    Figure 119: Asia Pacific Drug Testing Market Value Share (%) and BPS Analysis by End-use, 2023-2033

    Figure 120: Asia Pacific Drug Testing Market Y-o-Y Growth (%) Projections by End-use, 2023-2033

    Figure 121: Asia Pacific Drug Testing Market Attractiveness by Component , 2023-2033

    Figure 122: Asia Pacific Drug Testing Market Attractiveness by Sample Type, 2023-2033

    Figure 123: Asia Pacific Drug Testing Market Attractiveness by Drug Type , 2023-2033

    Figure 124: Asia Pacific Drug Testing Market Attractiveness by End-use, 2023-2033

    Figure 125: Asia Pacific Drug Testing Market Attractiveness by Country, 2023-2033

    Figure 126: Middle East and Africa Drug Testing Market Value (US$ Mn) by Component , 2023-2033

    Figure 127: Middle East and Africa Drug Testing Market Value (US$ Mn) by Sample Type, 2023-2033

    Figure 128: Middle East and Africa Drug Testing Market Value (US$ Mn) by Drug Type , 2023-2033

    Figure 129: Middle East and Africa Drug Testing Market Value (US$ Mn) by End-use, 2023-2033

    Figure 130: Middle East and Africa Drug Testing Market Value (US$ Mn) by Country, 2023-2033

    Figure 131: Middle East and Africa Drug Testing Market Value (US$ Mn) Analysis by Country, 2018-2033

    Figure 132: Middle East and Africa Drug Testing Market Value Share (%) and BPS Analysis by Country, 2023-2033

    Figure 133: Middle East and Africa Drug Testing Market Y-o-Y Growth (%) Projections by Country, 2023-2033

    Figure 134: Middle East and Africa Drug Testing Market Value (US$ Mn) Analysis by Component , 2018-2033

    Figure 135: Middle East and Africa Drug Testing Market Value Share (%) and BPS Analysis by Component , 2023-2033

    Figure 136: Middle East and Africa Drug Testing Market Y-o-Y Growth (%) Projections by Component , 2023-2033

    Figure 137: Middle East and Africa Drug Testing Market Value (US$ Mn) Analysis by Sample Type, 2018-2033

    Figure 138: Middle East and Africa Drug Testing Market Value Share (%) and BPS Analysis by Sample Type, 2023-2033

    Figure 139: Middle East and Africa Drug Testing Market Y-o-Y Growth (%) Projections by Sample Type, 2023-2033

    Figure 140: Middle East and Africa Drug Testing Market Value (US$ Mn) Analysis by Drug Type , 2018-2033

    Figure 141: Middle East and Africa Drug Testing Market Value Share (%) and BPS Analysis by Drug Type , 2023-2033

    Figure 142: Middle East and Africa Drug Testing Market Y-o-Y Growth (%) Projections by Drug Type , 2023-2033

    Figure 143: Middle East and Africa Drug Testing Market Value (US$ Mn) Analysis by End-use, 2018-2033

    Figure 144: Middle East and Africa Drug Testing Market Value Share (%) and BPS Analysis by End-use, 2023-2033

    Figure 145: Middle East and Africa Drug Testing Market Y-o-Y Growth (%) Projections by End-use, 2023-2033

    Figure 146: Middle East and Africa Drug Testing Market Attractiveness by Component , 2023-2033

    Figure 147: Middle East and Africa Drug Testing Market Attractiveness by Sample Type, 2023-2033

    Figure 148: Middle East and Africa Drug Testing Market Attractiveness by Drug Type , 2023-2033

    Figure 149: Middle East and Africa Drug Testing Market Attractiveness by End-use, 2023-2033

    Figure 150: Middle East and Africa Drug Testing Market Attractiveness by Country, 2023-2033

Copyright © Transparency Market Research, Inc. All Rights reserved